Bianca Heidersdorf

Medical Manager Hemophilia
Roche Pharma AG, Grenzach-Wyhlen, Germany
Grenzach-Wyhlen, Baden-Wurttemberg, Germany

Presentation(s):

• OC 43.4 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: interim analysis of the non-interventional study EMIIL

  Monday, June 26, 2023
  15:30 – 15:45 ET